Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CME GROUP INC.CME · Entity 2909 | Director | June 25, 2026 | June 29, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CME GROUP INC.
Report date June 25, 2026 · Filed June 29, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock Class ASEC Table I · non-derivative | Direct | 43,652 |
Reported balance
After 2026-06-25 transaction · row 1
1 source rowRow 1 · 2026-06-25 · Grant · Acquired 645 · Balance 43,652 F1: Represents a grant of fully vested shares of Class A Common Stock issued to the Reporting Person as part of the Issuer's annual equity compensation program for non-employee directors under the CME Group Director Stock Plan. These shares are not subject to any vesting conditions. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents a grant of fully vested shares of Class A Common Stock issued to the Reporting Person as part of the Issuer's annual equity compensation program for non-employee directors under the CME Group Director Stock Plan. These shares are not subject to any vesting conditions.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 16, 2017 Filed Sep 19, 2017 18:36 UTC | CME GROUP INC. CME · Entity 2909 | Tax withholdingCommon Stock Class A | 715 | $131.29 | $93,872.35 |
DisclosureSEC source: 0001156375-17-000093 · edgardoc.xml · nonDerivative · entry 3 Durkin Bryan T · CIK 0001341363 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,417 F2 · shares: Mr. Durkin surrendered shares to the Company in order to fulfill tax withholding obligations upon the vesting of restricted stock on 9/16/17. Read SEC document |
| September 15, 2017 Filed Sep 19, 2017 18:36 UTC | CME GROUP INC. CME · Entity 2909 | Tax withholdingCommon Stock Class A | 2,746 | $131.29 | $360,522.34 |
DisclosureSEC source: 0001156375-17-000093 · edgardoc.xml · nonDerivative · entry 2 Durkin Bryan T · CIK 0001341363 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,132 F1 · shares: Mr. Durkin surrendered shares to the Company in order to fulfill tax withholding obligations upon the vesting of restricted stock on 9/15/17. Read SEC document |
| September 15, 2017 Filed Sep 19, 2017 18:36 UTC | CME GROUP INC. CME · Entity 2909 | GrantCommon Stock Class A | 9,140 | $0.00 | $0.00 |
DisclosureSEC source: 0001156375-17-000093 · edgardoc.xml · nonDerivative · entry 1 Durkin Bryan T · CIK 0001341363 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,878 Read SEC document |
| August 08, 2017 Filed Aug 9, 2017 15:41 UTC | CME GROUP INC. CME · Entity 2909 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 9,200 | $0.00 Strike: $109.72 | $0.00 |
DisclosureSEC source: 0001156375-17-000084 · edgardoc.xml · derivative · entry 3 Durkin Bryan T · CIK 0001341363 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock Class A · 9,200 shares Expires 2017-09-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: As of September 14, 2012, this option vested with respect to 100% of the option. Read SEC document |
| August 08, 2017 Filed Aug 9, 2017 15:41 UTC | CME GROUP INC. CME · Entity 2909 | SaleCommon Stock Class A | 9,200 | $125.13 | $1,151,178.52 |
DisclosureSEC source: 0001156375-17-000084 · edgardoc.xml · nonDerivative · entry 2 Durkin Bryan T · CIK 0001341363 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,738 Read SEC document |
| August 08, 2017 Filed Aug 9, 2017 15:41 UTC | CME GROUP INC. CME · Entity 2909 | Exercise / conversionCommon Stock Class A | 9,200 | $109.72 | $1,009,424.00 |
DisclosureSEC source: 0001156375-17-000084 · edgardoc.xml · nonDerivative · entry 1 Durkin Bryan T · CIK 0001341363 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,938 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 15, 2017 Filed Mar 17, 2017 22:35 UTC | CME GROUP INC. CME · Entity 2909 | GrantCommon Stock Class A | 14,640 | $0.00 | $0.00 |
DisclosureSEC source: 0001156375-17-000028 · edgardoc.xml · nonDerivative · entry 2 Durkin Bryan T · CIK 0001341363 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,738 F2 · shares: Represents shares earned from a 2013 performance share award based upon the company's achievement of cash earnings per share growth and total shareholder return relative to the S&P 500 measured over 2014-2016. Read SEC document |
| March 15, 2017 Filed Mar 17, 2017 22:35 UTC | CME GROUP INC. CME · Entity 2909 | Tax withholdingCommon Stock Class A | 6,582 | $124.74 | $821,038.68 |
DisclosureSEC source: 0001156375-17-000028 · edgardoc.xml · nonDerivative · entry 1 Durkin Bryan T · CIK 0001341363 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,098 F1 · shares: Mr. Durkin surrendered shares to the Company in order to fulfill tax withholding obligations in connection with the receipt of the performance share award. Read SEC document |
| December 28, 2016 Filed Dec 29, 2016 22:53 UTC | CME GROUP INC. CME · Entity 2909 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 12,280 | $0.00 Strike: $54.37 | $0.00 |
DisclosureSEC source: 0001156375-16-000267 · edgardoc.xml · derivative · entry 6 Durkin Bryan T · CIK 0001341363 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock Class A · 12,280 shares Expires 2021-09-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: On September 15, 2015, these options vested with respect to 100% of the granted number of shares covered by the option. Read SEC document |
| December 28, 2016 Filed Dec 29, 2016 22:53 UTC | CME GROUP INC. CME · Entity 2909 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 2,606 | $0.00 Strike: $54.30 | $0.00 |
DisclosureSEC source: 0001156375-16-000267 · edgardoc.xml · derivative · entry 5 Durkin Bryan T · CIK 0001341363 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock Class A · 2,606 shares Expires 2020-09-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: On September 15, 2014, these options vested with respect to 100% of the granted number of shares covered by the option. Read SEC document |
| December 28, 2016 Filed Dec 29, 2016 22:53 UTC | CME GROUP INC. CME · Entity 2909 | SaleCommon Stock Class A | 2,606 | $116.39 | $303,317.29 |
DisclosureSEC source: 0001156375-16-000267 · edgardoc.xml · nonDerivative · entry 4 Durkin Bryan T · CIK 0001341363 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,680 F1 · shares: This sale was completed pursuant to the terms of a pre-arranged trading plan established in accordance with Rule 10b5-1. F2 · price: On December 28, 2016, Mr. Durkin sold an aggregate of 14,886 shares of CME Group Class A common stock. For reporting purposes, the sales prices within a $1 range have been aggregated and the weighted average sales price has been reported. The price ranges were: $115.87 to $115.97; $116.00 to $116.87; and $117.09 to $117.18. The Company maintains a record of the transactions and copies will be provided upon request. Read SEC document |
| December 28, 2016 Filed Dec 29, 2016 22:53 UTC | CME GROUP INC. CME · Entity 2909 | Exercise / conversionCommon Stock Class A | 2,606 | $54.30 | $141,505.80 |
DisclosureSEC source: 0001156375-16-000267 · edgardoc.xml · nonDerivative · entry 3 Durkin Bryan T · CIK 0001341363 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,286 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 28, 2016 Filed Dec 29, 2016 22:53 UTC | CME GROUP INC. CME · Entity 2909 | SaleCommon Stock Class A | 12,280 | $116.39 | $1,429,292.53 |
DisclosureSEC source: 0001156375-16-000267 · edgardoc.xml · nonDerivative · entry 2 Durkin Bryan T · CIK 0001341363 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,680 F1 · shares: This sale was completed pursuant to the terms of a pre-arranged trading plan established in accordance with Rule 10b5-1. F2 · price: On December 28, 2016, Mr. Durkin sold an aggregate of 14,886 shares of CME Group Class A common stock. For reporting purposes, the sales prices within a $1 range have been aggregated and the weighted average sales price has been reported. The price ranges were: $115.87 to $115.97; $116.00 to $116.87; and $117.09 to $117.18. The Company maintains a record of the transactions and copies will be provided upon request. Read SEC document |
| December 28, 2016 Filed Dec 29, 2016 22:53 UTC | CME GROUP INC. CME · Entity 2909 | Exercise / conversionCommon Stock Class A | 12,280 | $54.37 | $667,663.60 |
DisclosureSEC source: 0001156375-16-000267 · edgardoc.xml · nonDerivative · entry 1 Durkin Bryan T · CIK 0001341363 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,960 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 30, 2016 Filed Dec 1, 2016 19:46 UTC | CME GROUP INC. CME · Entity 2909 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 15,000 | $0.00 Strike: $54.30 | $0.00 |
DisclosureSEC source: 0001156375-16-000257 · edgardoc.xml · derivative · entry 3 Durkin Bryan T · CIK 0001341363 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,606 Underlying: Common Stock Class A · 15,000 shares Expires 2020-09-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: On September 15, 2014, these options vested with respect to 100% of the granted number of shares covered by the option. Read SEC document |
| November 30, 2016 Filed Dec 1, 2016 19:46 UTC | CME GROUP INC. CME · Entity 2909 | SaleCommon Stock Class A | 15,000 | $112.85 | $1,692,735.00 |
DisclosureSEC source: 0001156375-16-000257 · edgardoc.xml · nonDerivative · entry 2 Durkin Bryan T · CIK 0001341363 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,680 F1 · shares: This sale was completed pursuant to the terms of a pre-arranged trading plan established in accordance with Rule 10b5-1. F2 · price: On November 30, 2016, Mr. Durkin sold an aggregate of 15,000 shares of CME Group Class A common stock. For reporting purposes, the sales prices within a $1 range have been aggregated and the weighted average sales price has been reported. The price ranges were: $112.67 to $112.98 and $113.00 to $113.29. The Company maintains a record of the transactions and copies will be provided upon request. Read SEC document |
| November 30, 2016 Filed Dec 1, 2016 19:46 UTC | CME GROUP INC. CME · Entity 2909 | Exercise / conversionCommon Stock Class A | 15,000 | $54.30 | $814,500.00 |
DisclosureSEC source: 0001156375-16-000257 · edgardoc.xml · nonDerivative · entry 1 Durkin Bryan T · CIK 0001341363 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,680 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 31, 2016 Filed Nov 1, 2016 19:43 UTC | CME GROUP INC. CME · Entity 2909 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 10,226 | $0.00 Strike: $56.87 | $0.00 |
DisclosureSEC source: 0001156375-16-000250 · edgardoc.xml · derivative · entry 6 Durkin Bryan T · CIK 0001341363 · Sr MD Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock Class A · 10,226 shares Expires 2019-09-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: On September 15, 2013, these options vested with respect to 100% of the granted number of shares covered by the option. Read SEC document |
| October 31, 2016 Filed Nov 1, 2016 19:43 UTC | CME GROUP INC. CME · Entity 2909 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 4,774 | $0.00 Strike: $54.30 | $0.00 |
DisclosureSEC source: 0001156375-16-000250 · edgardoc.xml · derivative · entry 5 Durkin Bryan T · CIK 0001341363 · Sr MD Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,606 Underlying: Common Stock Class A · 4,774 shares Expires 2020-09-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: On September 15, 2014, these options vested with respect to 100% of the granted number of shares covered by the option. Read SEC document |
| October 31, 2016 Filed Nov 1, 2016 19:43 UTC | CME GROUP INC. CME · Entity 2909 | SaleCommon Stock Class A | 10,226 | $100.00 | $1,022,557.05 |
DisclosureSEC source: 0001156375-16-000250 · edgardoc.xml · nonDerivative · entry 4 Durkin Bryan T · CIK 0001341363 · Sr MD Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,680 F1 · shares: This sale was completed pursuant to the terms of a pre-arranged trading plan established in accordance with Rule 10b5-1. F2 · price: On October 31, 2016, Mr. Durkin sold an aggregate of 15,000 shares of CME Group Class A common stock. For reporting purposes, the sales prices within a $1 range have been aggregated and the weighted average sales price has been reported. The price ranges were: $99.59 to $99.99 and $100.00 to $100.25. The Company maintains a record of the transactions and copies will be provided upon request. Read SEC document |
| October 31, 2016 Filed Nov 1, 2016 19:43 UTC | CME GROUP INC. CME · Entity 2909 | Exercise / conversionCommon Stock Class A | 10,226 | $56.87 | $581,552.62 |
DisclosureSEC source: 0001156375-16-000250 · edgardoc.xml · nonDerivative · entry 3 Durkin Bryan T · CIK 0001341363 · Sr MD Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,906 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 31, 2016 Filed Nov 1, 2016 19:43 UTC | CME GROUP INC. CME · Entity 2909 | SaleCommon Stock Class A | 4,774 | $100.00 | $477,379.95 |
DisclosureSEC source: 0001156375-16-000250 · edgardoc.xml · nonDerivative · entry 2 Durkin Bryan T · CIK 0001341363 · Sr MD Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,680 F1 · shares: This sale was completed pursuant to the terms of a pre-arranged trading plan established in accordance with Rule 10b5-1. F2 · price: On October 31, 2016, Mr. Durkin sold an aggregate of 15,000 shares of CME Group Class A common stock. For reporting purposes, the sales prices within a $1 range have been aggregated and the weighted average sales price has been reported. The price ranges were: $99.59 to $99.99 and $100.00 to $100.25. The Company maintains a record of the transactions and copies will be provided upon request. Read SEC document |
| October 31, 2016 Filed Nov 1, 2016 19:43 UTC | CME GROUP INC. CME · Entity 2909 | Exercise / conversionCommon Stock Class A | 4,774 | $54.30 | $259,228.20 |
DisclosureSEC source: 0001156375-16-000250 · edgardoc.xml · nonDerivative · entry 1 Durkin Bryan T · CIK 0001341363 · Sr MD Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,454 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 28, 2016 Filed Sep 30, 2016 17:06 UTC | CME GROUP INC. CME · Entity 2909 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 11,600 | $0.00 Strike: $83.88 | $0.00 |
DisclosureSEC source: 0001156375-16-000242 · edgardoc.xml · derivative · entry 7 Durkin Bryan T · CIK 0001341363 · Sr MD Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock Class A · 11,600 shares Expires 2018-06-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: These options were granted on June 16, 2008. They vest over a five-year period, with 20% vesting one year after the grant date and 20% vesting on that same date in each of the following three years, subject to acceleration or termination in certain circumstances. Read SEC document |
| September 28, 2016 Filed Sep 30, 2016 17:06 UTC | CME GROUP INC. CME · Entity 2909 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 1,734 | $0.00 Strike: $56.87 | $0.00 |
DisclosureSEC source: 0001156375-16-000242 · edgardoc.xml · derivative · entry 6 Durkin Bryan T · CIK 0001341363 · Sr MD Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,226 Underlying: Common Stock Class A · 1,734 shares Expires 2019-09-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: These options were granted on September 15, 2009. They vest over a four-year period, with 25% vesting one year after the grant date and 25% vesting on that same date in each of the following three years, subject to acceleration or termination in certain circumstances. Read SEC document |
| September 28, 2016 Filed Sep 30, 2016 17:06 UTC | CME GROUP INC. CME · Entity 2909 | SaleCommon Stock Class A | 1,656 | $105.20 | $174,211.20 |
DisclosureSEC source: 0001156375-16-000242 · edgardoc.xml · nonDerivative · entry 5 Durkin Bryan T · CIK 0001341363 · Sr MD Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,680 F1 · shares: This sale was completed pursuant to the terms of a pre-arranged trading plan established in accordance with Rule 10b5-1. F3 · price: On September 28, 2016, Mr. Durkin sold an aggregate of 1,656 shares of CME Group Class A common stock. For reporting purposes, the sales prices within a $1 range have been aggregated and the weighted average sales price has been reported. The price ranges were: $105.02 to $105.51. The Company maintains a record of the transactions and copies will be provided upon request. Read SEC document |
| September 28, 2016 Filed Sep 30, 2016 17:06 UTC | CME GROUP INC. CME · Entity 2909 | SaleCommon Stock Class A | 1,734 | $105.09 | $182,231.09 |
DisclosureSEC source: 0001156375-16-000242 · edgardoc.xml · nonDerivative · entry 4 Durkin Bryan T · CIK 0001341363 · Sr MD Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,336 F1 · shares: This sale was completed pursuant to the terms of a pre-arranged trading plan established in accordance with Rule 10b5-1. F2 · price: On September 28, 2016, Mr. Durkin sold an aggregate of 13,334 shares of CME Group Class A common stock. For reporting purposes, the sales prices within a $1 range have been aggregated and the weighted average sales price has been reported. The price ranges were: $107.09 to $107.99 and $108.01 to $108.62. The Company maintains a record of the transactions and copies will be provided upon request. Read SEC document |
| September 28, 2016 Filed Sep 30, 2016 17:06 UTC | CME GROUP INC. CME · Entity 2909 | Exercise / conversionCommon Stock Class A | 1,734 | $56.87 | $98,612.58 |
DisclosureSEC source: 0001156375-16-000242 · edgardoc.xml · nonDerivative · entry 3 Durkin Bryan T · CIK 0001341363 · Sr MD Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,070 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 28, 2016 Filed Sep 30, 2016 17:06 UTC | CME GROUP INC. CME · Entity 2909 | SaleCommon Stock Class A | 11,600 | $105.09 | $1,219,077.64 |
DisclosureSEC source: 0001156375-16-000242 · edgardoc.xml · nonDerivative · entry 2 Durkin Bryan T · CIK 0001341363 · Sr MD Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,336 F1 · shares: This sale was completed pursuant to the terms of a pre-arranged trading plan established in accordance with Rule 10b5-1. F2 · price: On September 28, 2016, Mr. Durkin sold an aggregate of 13,334 shares of CME Group Class A common stock. For reporting purposes, the sales prices within a $1 range have been aggregated and the weighted average sales price has been reported. The price ranges were: $107.09 to $107.99 and $108.01 to $108.62. The Company maintains a record of the transactions and copies will be provided upon request. Read SEC document |
| September 28, 2016 Filed Sep 30, 2016 17:06 UTC | CME GROUP INC. CME · Entity 2909 | Exercise / conversionCommon Stock Class A | 11,600 | $83.88 | $973,008.00 |
DisclosureSEC source: 0001156375-16-000242 · edgardoc.xml · nonDerivative · entry 1 Durkin Bryan T · CIK 0001341363 · Sr MD Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,936 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 16, 2016 Filed Sep 19, 2016 20:21 UTC | CME GROUP INC. CME · Entity 2909 | Tax withholdingCommon Stock Class A | 713 | $109.65 | $78,180.45 |
DisclosureSEC source: 0001156375-16-000229 · edgardoc.xml · nonDerivative · entry 2 Durkin Bryan T · CIK 0001341363 · Sr MD Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,336 F1 · shares: Mr. Durkin surrendered shares to the Company in order to fulfill tax withholding obligations upon the vesting of restricted stock on 9/16/2016. Read SEC document |
| September 15, 2016 Filed Sep 16, 2016 19:38 UTC | CME GROUP INC. CME · Entity 2909 | Tax withholdingCommon Stock Class A | 1,695 | $109.28 | $185,229.60 |
DisclosureSEC source: 0001156375-16-000214 · edgardoc.xml · nonDerivative · entry 2 Durkin Bryan T · CIK 0001341363 · Sr MD Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,441 F2 · shares: Mr. Durkin surrendered shares to the Company in order to fulfill tax withholding obligations upon the vesting of restricted stock on 9/15/2016. Read SEC document |
| September 15, 2016 Filed Sep 19, 2016 20:21 UTC | CME GROUP INC. CME · Entity 2909 | GrantCommon Stock Class A | 9,608 | $0.00 | $0.00 |
DisclosureSEC source: 0001156375-16-000229 · edgardoc.xml · nonDerivative · entry 1 Durkin Bryan T · CIK 0001341363 · Sr MD Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,049 Read SEC document |
| September 14, 2016 Filed Sep 16, 2016 19:38 UTC | CME GROUP INC. CME · Entity 2909 | Tax withholdingCommon Stock Class A | 831 | $107.55 | $89,374.05 |
DisclosureSEC source: 0001156375-16-000214 · edgardoc.xml · nonDerivative · entry 1 Durkin Bryan T · CIK 0001341363 · Sr MD Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,136 F1 · shares: Mr. Durkin surrendered shares to the Company in order to fulfill tax withholding obligations upon the vesting of restricted stock on 9/14/2016. Read SEC document |
| September 06, 2016 Filed Sep 8, 2016 17:05 UTC | CME GROUP INC. CME · Entity 2909 | SaleCommon Stock Class A | 15,000 | $107.75 | $1,616,250.00 |
DisclosureSEC source: 0001156375-16-000207 · edgardoc.xml · nonDerivative · entry 2 Durkin Bryan T · CIK 0001341363 · Sr MD Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,967 F2 · shares: This sale was completed pursuant to the terms of a pre-arranged trading plan established in accordance with Rule 10b5-1. F3 · price: On September 6, 2016, Mr. Durkin sold an aggregate of 15,000 shares of CME Group Class A common stock. For reporting purposes, the sales prices within a $1 range have been aggregated and the weighted average sales price has been reported. The price ranges were: $107.09 to $107.99 and $108.01 to $108.62. The Company maintains a record of the transactions and copies will be provided upon request. Read SEC document |
| June 14, 2016 Filed Sep 8, 2016 17:05 UTC | CME GROUP INC. CME · Entity 2909 | GiftCommon Stock Class A | 1,014 | $0.00 | $0.00 |
DisclosureSEC source: 0001156375-16-000207 · edgardoc.xml · nonDerivative · entry 1 Durkin Bryan T · CIK 0001341363 · Sr MD Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,967 F1 · shares: On June 14, 2016, the reporting person gifted an aggregate of 1,014 shares of Class A common stock as a charitable contribution. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.